BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 9205106)

  • 1. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH
    Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of proviral sequences, but not at the common integration sites of the FGF8 locus, in an androgen-dependent mouse mammary Shionogi carcinoma.
    Kuriki K; Kamiakito T; Yoshida H; Saito K; Fukayama M; Tanaka A
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1147-56. PubMed ID: 11075944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
    Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
    Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
    Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
    Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA; Troyer KL; Lee DC
    Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Fgf8 in S115 mouse mammary tumor cells is associated with genomic integration of mouse mammary tumor virus.
    Valve EM; Tasanen MJ; Ruohola JK; Härkönen PL
    Biochem Biophys Res Commun; 1998 Sep; 250(3):805-8. PubMed ID: 9784427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
    Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression array analyses predict increased proto-oncogene expression in MMTV induced mammary tumors.
    Popken-Harris P; Kirchhof N; Harrison B; Harris LF
    Virus Res; 2006 Aug; 119(2):177-86. PubMed ID: 16469401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNT and FGF gene clusters (review).
    Katoh M
    Int J Oncol; 2002 Dec; 21(6):1269-73. PubMed ID: 12429977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene.
    Morris DW; Dutra JC
    Virology; 1997 Nov; 238(1):161-5. PubMed ID: 9375020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer.
    Callahan R
    Breast Cancer Res Treat; 1996; 39(1):33-44. PubMed ID: 8738604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer.
    van Leeuwen F; Nusse R
    Semin Cancer Biol; 1995 Jun; 6(3):127-33. PubMed ID: 7495980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse mammary tumor virus derived from wild mice does not target Notch-4 protooncogene for the development of mammary tumors in inbred mice.
    Sarkar NH
    Virology; 2009 May; 388(1):121-7. PubMed ID: 19329137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis.
    MacArthur CA; Shankar DB; Shackleford GM
    J Virol; 1995 Apr; 69(4):2501-7. PubMed ID: 7884899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
    Callahan R; Smith GH
    Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
    Li YX; Papkoff J; Sarkar NH
    Virology; 1999 Mar; 255(1):138-49. PubMed ID: 10049829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.